Cargando…

Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment

Radiotherapy is one of the mainstays of glioblastoma (GBM) treatment. This study aims to investigate and characterise differences in protein expression patterns in brain tumour tissue following radiotherapy, in order to gain a more detailed understanding of the biological effects. Rat BT4C glioma ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Wibom, C, Pettersson, F, Sjöström, M, Henriksson, R, Johansson, M, Bergenheim, A T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361353/
https://www.ncbi.nlm.nih.gov/pubmed/16736004
http://dx.doi.org/10.1038/sj.bjc.6603190
_version_ 1782153195799183360
author Wibom, C
Pettersson, F
Sjöström, M
Henriksson, R
Johansson, M
Bergenheim, A T
author_facet Wibom, C
Pettersson, F
Sjöström, M
Henriksson, R
Johansson, M
Bergenheim, A T
author_sort Wibom, C
collection PubMed
description Radiotherapy is one of the mainstays of glioblastoma (GBM) treatment. This study aims to investigate and characterise differences in protein expression patterns in brain tumour tissue following radiotherapy, in order to gain a more detailed understanding of the biological effects. Rat BT4C glioma cells were implanted into the brain of two groups of 12 BDIX-rats. One group received radiotherapy (12 Gy single fraction). Protein expression in normal and tumour brain tissue, collected at four different time points after irradiation, were analysed using surface enhanced laser desorption/ionisation – time of flight – mass spectrometry (SELDI-TOF-MS). Mass spectrometric data were analysed by principal component analysis (PCA) and partial least squares (PLS). Using these multivariate projection methods we detected differences between tumours and normal tissue, radiation treatment-induced changes and temporal effects. 77 peaks whose intensity significantly changed after radiotherapy were discovered. The prompt changes in the protein expression following irradiation might help elucidate biological events induced by radiation. The combination of SELDI-TOF-MS with PCA and PLS seems to be well suited for studying these changes. In a further perspective these findings may prove to be useful in the development of new GBM treatment approaches.
format Text
id pubmed-2361353
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23613532009-09-10 Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment Wibom, C Pettersson, F Sjöström, M Henriksson, R Johansson, M Bergenheim, A T Br J Cancer Translational Therapeutics Radiotherapy is one of the mainstays of glioblastoma (GBM) treatment. This study aims to investigate and characterise differences in protein expression patterns in brain tumour tissue following radiotherapy, in order to gain a more detailed understanding of the biological effects. Rat BT4C glioma cells were implanted into the brain of two groups of 12 BDIX-rats. One group received radiotherapy (12 Gy single fraction). Protein expression in normal and tumour brain tissue, collected at four different time points after irradiation, were analysed using surface enhanced laser desorption/ionisation – time of flight – mass spectrometry (SELDI-TOF-MS). Mass spectrometric data were analysed by principal component analysis (PCA) and partial least squares (PLS). Using these multivariate projection methods we detected differences between tumours and normal tissue, radiation treatment-induced changes and temporal effects. 77 peaks whose intensity significantly changed after radiotherapy were discovered. The prompt changes in the protein expression following irradiation might help elucidate biological events induced by radiation. The combination of SELDI-TOF-MS with PCA and PLS seems to be well suited for studying these changes. In a further perspective these findings may prove to be useful in the development of new GBM treatment approaches. Nature Publishing Group 2006-06-19 2006-05-30 /pmc/articles/PMC2361353/ /pubmed/16736004 http://dx.doi.org/10.1038/sj.bjc.6603190 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Translational Therapeutics
Wibom, C
Pettersson, F
Sjöström, M
Henriksson, R
Johansson, M
Bergenheim, A T
Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
title Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
title_full Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
title_fullStr Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
title_full_unstemmed Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
title_short Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
title_sort protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
topic Translational Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361353/
https://www.ncbi.nlm.nih.gov/pubmed/16736004
http://dx.doi.org/10.1038/sj.bjc.6603190
work_keys_str_mv AT wibomc proteinexpressioninexperimentalmalignantgliomavariesovertimeandisalteredbyradiotherapytreatment
AT petterssonf proteinexpressioninexperimentalmalignantgliomavariesovertimeandisalteredbyradiotherapytreatment
AT sjostromm proteinexpressioninexperimentalmalignantgliomavariesovertimeandisalteredbyradiotherapytreatment
AT henrikssonr proteinexpressioninexperimentalmalignantgliomavariesovertimeandisalteredbyradiotherapytreatment
AT johanssonm proteinexpressioninexperimentalmalignantgliomavariesovertimeandisalteredbyradiotherapytreatment
AT bergenheimat proteinexpressioninexperimentalmalignantgliomavariesovertimeandisalteredbyradiotherapytreatment